Overview - Flavonoids: A new family of benzodiazepine receptor ligands

Neurochemical Research

Volumn 22, Issue 4, 1997, Pages 419-425

  Medina, Jorge H ^a   Viola, Haydee ^a   Wolfman, Claudia ^a   Marder, Mariel ^b   Wasowski, Cristina ^b   Calvo, Daniel ^a   Paladini, Alejandro C ^b,c  

^a Facultad de Medicina   (Argentina)

^b Instituto de Quimica y Fisicoquimica Biologicas Buenos Aires   (Argentina)

^c UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

anxiolysis; benzodiazepine receptors; Flavonoids; partial agonist

Indexed keywords

AMENTOFLAVONE; BENZODIAZEPINE RECEPTOR; FLAVONE DERIVATIVE; FLAVONOID; TRANQUILIZER;

ALCOHOL CONSUMPTION; AMNESIA; ARTICLE; ATAXIA; DRUG POTENTIATION; DRUG RECEPTOR BINDING; DRUG TOLERANCE; MUSCLE RELAXATION; PRIORITY JOURNAL; SEDATION; TRANQUILIZING ACTIVITY;

ATAXIA;

EID: 0030933050     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1027303609517     Document Type: Article

References (19)

1. Mohler, H., and Okada, T. 1977. Benzodiazepine receptors: demonstration in the central nervous system. Science 198:849-851.
2. Squires, R. F., and Braestrup, C. 1977. Benzodiazepine receptors in rat brain. Nature 266:732-734.
3. A receptors subtypes really occur in the brain? TINS 19:139-143.
4. Olsen, R. W., and Venter, J. C. 1986. Benzodiazepine/GABA receptors and chloride channels. Structural and Functional Properties. Alan R. Liss, New York.
5. A receptors: cell-specific expression, pharmacology, and regulation. Neurochem. Res. 20:631-638.
6. Phillis, J. W., and O'Regan, M. H. 1988. The role of adenosine in the central actions of the benzodiazepines. Prog. Neuropsychopharmacol. & Biol. Psychiat. 12:389-404.
7. Costa, E., and Guidotti, A. 1996. Benzodiazepines on trial: a research strategy for their rehabilitation. TIPS: 17:192-200.
8. Siegharth, W., and Karobath, M. 1980. Molecular heterogeneity of benzodiazepine receptors. Nature 285:826-828.
9. Trifiletti, R. R., Lo, M. M. S., and Snyder, S. H. 1984. Kinetics differences between type I and type II benzodiazepine receptors. Mol. Pharmacol. 26:228-234.
10. 3H] flunitrazepam binding sites. J. Neurochem. 49:890-896.
11. Woods, J. H., Katz, J. L., and Winger, G. 1992. Benzodiazepines: use, abuse and consequences. Pharmacol. Rev. 44:151-347.
12. Pratt, J. A. 1991. Psychotropic drug tolerance and dependence: common underlying mechanism? Pages 2-28, in The Biological bases of drug tolerance and dependence, Academic Press.
13. Kales, A., Bixler, E., Vela-Bueno, A., Soldates, C. R., and Manfredi, R. L. 1987. Alprazolam: effects on sleep and withdrawal phenomena. J. Clin. Pharmacol. 27:508-515.
14. Miller, L. G., Woolverton, S., Greenblatt, D. J., Lopez, F., Beth Roy R., and Shader, R. 1989. Chronic benzodiazepine administration IV. Biochem Pharmacol. 38:3773-3777.
15. A receptor complex locus of change. Biochem. Soc. Symp. 59:135-151.
16. Nutt, D. J. 1986. Benzodiazepine dependence in the clinic: reason for anxiety. TIPS 7:457-460.
17. Griffiths, R. R., and Sannerud, C. A. 1987. Abuse liability of tranquilizers. In Rational use of psychotropic drugs with special emphasis on tranquilizers in non-psychiatric setting. M. E. Vartanian et al. (eds.) pages 23-29, Excerpta Med., Amsterdam.
18. Rickels, K., Schweizer, E., Case, W. G., and Greenblatt, D. J. 1990. Long-term therapeutic use of benzodiazepines. I. Effect of abrupt discontinuation. Arch. Gen. Psychiat. 47:899-907.
19. Thiebot, M. H. 1985. Some evidence for amnesic-like effects of benzodiazepines in animals. Neurosci. Biobehav. Rev. 9:95-100.